Neil Bargh (L); Richard Wales, Ph.D.
Sartorius, an international partner of life science research and the biopharmaceutical industry, announces that Richard Wales, Ph.D. and Neal Bargh were named the 2022 ESACT (European Society for Animal Cell Technology) Innovation Award winners at a ceremony at ESACT’s 27th annual meeting in Lisbon, Portugal. According to ESACT, the award recognizes outstanding innovators in the field of animal cell culture technology (ACCT) and highlights their landmark contributions and industry impact.
Wales and Bargh reportedly were instrumental in the development, design and technical evolution of the Ambr bioreactor systems, which closely mimic production bioreactors and which have been widely adopted by the biopharmaceutical industry worldwide to accelerate process development, enhance process understanding and bring lifesaving biotherapeutics to the marketplace faster, according to the company.
Wales, with a Ph.D. in molecular biology, has been with Sartorius since 2013. Prior to joining Sartorius, in 2001, he began his involvement with the identification and development of integrated automated systems in cell culture, protein purification and vial filling including the Ambr products.
Bargh, with a master’s in engineering, joined Sartorius in 2013 and has been instrumental in the development of Ambr 15, Ambr 250 HT, Ambr 250 Modular and Ambr Crossflow, according to the company.
“We were driven to accelerate process development for our partners and assist in bringing lifesaving biotherapeutics to market more efficiently,” says Bargh in a press release from the company. “It brings me immense satisfaction to know that the Ambr systems have been adopted so widely across the world and I feel very honored that Richard and I have been selected for the ESACT Innovation Award.”
Read the press release at: www.sartorius.com
